GABPA_NEUROG2

CAP-SELEX sample NEUROG2_GABPA · 1 runs in PRJEB66722

Organism
Nucleic acid
DNA
Rounds available
R3
Sequences indexed
10,000

Top enriched sequences

More via API →
Sequence Length log2 FC P(active) Class Monotonicity
CATTATGGACGAGTTCGCTTCCCGTTTGTTTAATACCGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:7ed51f0ce03c
40
TGCGCACATCCGGTTAATCTGAGAAGCGTACGTTTCCGGT
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:7caff8bc1ddd
40
CATGAGCACTCGCCTCTACTTCCGGTGGAATAACGACGTA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:12c04845e2af
40
TCCTACCGGATGTACACATACGGTAGCGTCGAACATCAGC
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:06bb0d34d391
40
CGCCCCCCAACCCGAAGGAACATACAACGCAACAACCGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:a2b918718768
40
GCATATGGTGCAGAGGGACCGGAAGTTTATGGTACTGGGT
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:ae6c4059358b
40
GCCGGAAGTCCGCTAACAGTTACATGTCTAATCTCCCGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:45dce86d7b85
40
TCCCAGGTCTACTTCCGGTCACGCATTGGCCGGAAGTGTG
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:2428bdce42ed
40
ATGTTGTGGAAGTGGAAGCTTACGAACTTCCGGTTACTGG
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:2cf94e8a5dd1
40
CGTCCGGTCCCCTGCCCTCCCGTCATTCAGGCCCCCCGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:3a74ff3f7465
40
GAAAGCATGTGTGTCACATCCGGTTAGCGTGTGGCCTTGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:5d8d3accc5a1
40
TAAGGTGAAGCCCCGATAAGTATGGAATACTTCCGGTGAC
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:27b9eb4a323e
40
CTTTTCCTATTTGGGACCGGAAGCGTTGGCTTATAACTGG
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:b9bcf8088eb4
40
CATTACGAGAGTGGTAGGCGCCGGAAGTGAATGCAATTCC
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:5508a5a530bb
40
AAACCGTAAGTGTAACGTCCGGTTTCCTTGAGGCTCTTCG
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:8519a0824277
40
CGGATCTTGTTACGCCACAGCACTTCCTGGTCACTACGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:27b4babc183d
40
TCCGAGCTATTTCCGGTCCGGGTTAGCTGTCGCATACGCA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:d656c237437b
40
TAGACACGAATACAAAGCGGAAGTCGGTATGCACCCAGCG
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:611bcee4c5bf
40
GTCATGAAACTTCCGGTACCTTCGTACCGGACGTTGCGTG
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:a8cb1a8d031e
40
ACGCCACGCCCCGAAAGTTCCTCACGTCCGGTGCGAGCTA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:36383c1a9bbc
40
GGCAACTTCCGGAAGTGGCGCGCATCCTCCGGAAGTGCTC
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:8301eb225b9d
40
GTCGTCCAACATCTGCTAGACGTAAGCGTGCTTCCGTCTA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:44e65b5dfb9d
40
GGTACTGCATCACCGTTAAGCACGAACACTTCCGGTGATT
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:9bb82710ee89
40
TATAGAGTATCAGGAAGACTATCCCGCCTGGCCCGGAAGT
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:3f69249f7dd1
40
AAAGTCACTACTTCCGCTCGCCTCTAGCAATTTCCGGTCA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:6e018cf4343b
40
ACAGGGCTTTCACGTCCGGTCGCGGAAAAGATTAAACGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:40119b5a56b0
40
AACAACCGGAAGTGATCGCTCCCTCACTTACGGCCCTACT
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:eee4e1f77b21
40
CTGACACGATACTTGCCGAGGTGCATCATCTAGGCCGCAC
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:be60445736a1
40
CTACGCGTAAGTATACGGTACTTCCGGTAGCGGTTACCTC
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:8d47ac0c080d
40
GCGTACCCTTACTAATTCCGCAGACAGGAAGTTGTAGCTG
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:39bc90246b31
40
AGATTCGCCCGATAAGTACACTGCCGGGCTAGGTCAACGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:3dc2ea1c1780
40
CTACGCGCAACGTGAGGCCGTTCAGTAAACTTCCGGCGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:2a2b604e81cf
40
TGATAGATCATCCCATTCTATAGTCCTCGCCATATGACGG
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:7b5f7c16f963
40
GACTTCCGGTGTAACGCGGAAATAGCTCCGGTTCTCGGAT
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:091054844ea5
40
TTACATCCAAGTGACCTTCAAAGTAACGGAAGCAGCTGCT
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:ac1790a0a07b
40
GCGCTGAACTCGATATAACACTTCCGGTGTGTACACCGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:c27626bdd7df
40
AAGAGGCAATGCTCACAACTCCAAACGACTGAACACCGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:d044695bc544
40
CCGTAGTCACTTACTTCCGGTAATTATCGGCTTTACCGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:bdd4016666bd
40
CATCCTGTACTTACGGAAAACGTACCGGAAGTGTCGCGCA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:34e2acbe9b8f
40
TGCAGACGACGAAAGTCAGGGGTCTACTTCCGGTCATGCA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:9d7581109336
40
TACAGGAATCCTTCCGGTGGAACGCGAAAGTGATGAGGAG
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:39155ceddc5c
40
CTGATTACGCTAACACCTGTTTCCGGTTGCGTGTGAACTA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:2a50a134bb5c
40
GGCGCCTACAGCCATCACTGTCCAGATAACGACTCGTCTA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:422eaf7a888c
40
CCGCAACCACCGAATTTCCTGTTCATACCGGAAATAACGC
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:85f72bf33894
40
GCAGGAAGGAAGGTAGAGGAAACGTAAGGCAACGACCGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:65fb9bda36de
40
CCGTCGTGGCATTCTTCCGGTCGCGTGGGACATCGCTCAG
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:4a10a789fd7d
40
CCAGCCGCTACTTCCGGTGCGCTCAAAGCGATATACCGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:3a3f7bd163cd
40
ATGGACGTGCGAAGAAGATATGAGTGACGACATATCGCGT
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:b05aef3362cb
40
CTGGTCGTTAAACTTCCGGCGTGACGTTACCTACACCGGA
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:f4a15c47f374
40
CACGATCCGCACCCACCACACAACAGTACACCATTAACCG
PANAPTA:Q06546:GABPA_NEUROG2:PRJEB66722:R3:2332f53d130d
40

SELEX rounds

R3 ·final